1056264-66-4 Usage
General Description
2-bromo-3-chloro-6-fluorobenzaldehyde is an organic compound with the molecular formula C7H3BrClFO. It is a member of the benzaldehyde family and is characterized by the presence of bromine, chlorine, and fluorine atoms attached to a benzene ring. 2-bromo-3-chloro-6-fluorobenzaldehyde is commonly used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals. Its chemical properties make it a valuable building block for the production of diverse organic compounds. Overall, 2-bromo-3-chloro-6-fluorobenzaldehyde plays a crucial role in the chemical industry and serves as a valuable tool for the creation of numerous important products.
Check Digit Verification of cas no
The CAS Registry Mumber 1056264-66-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,5,6,2,6 and 4 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1056264-66:
(9*1)+(8*0)+(7*5)+(6*6)+(5*2)+(4*6)+(3*4)+(2*6)+(1*6)=144
144 % 10 = 4
So 1056264-66-4 is a valid CAS Registry Number.
1056264-66-4Relevant articles and documents
METHODS OF TREATING CREATINE TRANSPORTER DEFICIENCY
-
Paragraph 0537-0538, (2021/10/02)
Disclosed are methods of treating creatine transporter deficiency, comprising administering to a mammal in need thereof a therapeutically effective amount of a compound that increases transport of a substrate by a mutant or wild-type creatine transporter. Also disclosed are methods of increasing transport of guanidinoacetic acid or a salt thereof across the blood-brain barrier of a mammal, and methods of decreasing accumulation or the concentration of guanidinoacetic acid or a salt thereof in a mammalian cell.
INDAZOLES USED TO TREAT ESTROGEN RECEPTOR BETA MEDIATED DISORDERS
-
Page/Page column 25-26, (2008/12/07)
The present invention relates to novel indazole derivatives (I) having pharmacological activity, processes for their preparation, compositions containing them and uses of these compounds in the treatment of estrogen receptor beta mediated diseases.
